Atorvia Analysis: $255M Raised
What is Atorvia?
Targeted therapeutics for kidney failure
Location
Mississauga, Canada
Employees
1-10
Founded
2021
Product Features & Capabilities
- Novel therapeutics for kidney failure
- AI models for proteomic analysis
- Research on organ failure prevention
Use Cases
Develop targeted treatments for kidney failure patients; Utilize AI to analyze human proteome; Address health complications from kidney failure; Create therapies for patients requiring dialysis; Research into preventing organ failure
See something that needs updating? Suggest edits to this profile.